CCE connects local farms, foodies through Taste NY

From maple syrup to apple cider to goat's milk soap, New York farms are growing sales in partnership with Cornell Cooperative Extension and Taste NY stores across the state.

Cornell sharpens its strategic approach to external education

As of January 2020, Cornell will bring together eCornell, its online learning platform, and other external education programs as a new unit under the academic leadership of the Office of the Provost.

Things to Do, Oct. 25-Nov. 1, 2019

Events this week include Chocolatada! at Cornell Botanic Gardens; Halloween film screenings and costume parties at Cornell Cinema; a concert of train songs, and a podcast recording at the Johnson Museum.

Art and science provide fertile ground for research, teaching

Research projects investigating the sounds of soil bring the fields of soil science, art, bioacoustics, entomology and other disciplines together, and blend creative practice with scientific inquiry.

CCE’s Blocks in Bloom helps communities flourish

Rochester neighborhood reaps benefits of Cooperative Extension initiative run through Master Gardener Program and fueled by trained volunteers who provide research-based support to the public.

Study links high-salt diet and cognitive impairment

A high-salt diet may impair cognitive function by causing a deficiency of nitric oxide, which is vital for maintaining vascular health in the brain, according to a new study from Weill Cornell Medicine.

Mapping cancer’s drug resistance could improve treatment

Powerful lab and computational techniques developed by scientists at Weill Cornell Medicine and two other centers will enable scientists to map tumors’ ability to develop resistance to drugs. 

Public History Initiative launches at Cornell

Cornell has launched a new Public History Initiative, led by Stephen Vider, as part of the provost’s Radical Collaboration initiative focused on the humanities and the arts.

Universal flu vaccine developed at Cornell nearing human trials

A universal influenza vaccine developed with the potential to be longer lasting and more effective than commercially available vaccines is destined for human clinical trials, thanks to a $17.9 million grant from the National Institute of Allergy and Infectious Diseases.